Andropause, often referred to as male menopause, is a natural and gradual process characterized by a decline in testosterone levels in aging men. Unlike the more abrupt hormonal changes in women during menopause, andropause occurs over an extended period, typically starting in the late 40s or early 50s. This phase is marked by a range of physical, psychological, and emotional changes that can significantly impact a man's well-being. Physiologically, the decline in testosterone levels during andropause can lead to symptoms such as fatigue, reduced muscle mass, increased body fat, and diminished bone density. Men may also experience changes in sexual function, including a decline in libido and erectile dysfunction. Alongside these physical manifestations, andropause can influence mood and mental health, contributing to symptoms like irritability, depression, and difficulty concentrating. Addressing andropause often involves a multifaceted approach. Hormone replacement therapy (HRT) may be considered to restore testosterone levels and alleviate some symptoms. Lifestyle modifications, including regular exercise, a balanced diet, and stress management, can also play a crucial role in managing andropause-related symptoms. Additionally, open communication with healthcare providers is essential to tailor interventions based on individual needs and health considerations. Recognizing the impact of andropause on men's health is crucial for fostering a proactive approach to aging. By understanding and addressing the physical, psychological, and emotional aspects of andropause, individuals and healthcare professionals can collaborate to navigate this natural life stage and optimize overall well-being in the later years of a man's life.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia